Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings

Misuse of gabapentin and pregabalin: a marker for a more serious malaise?

(2016) Cathy Stannard   ADDICTION

Gabapentin misuse, abuse and diversion: a systematic review

(2016) Rachel V. Smith et al.   ADDICTION

A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database

(2016) Stefania Chiappini et al.   CNS DRUGS

Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone

(2016) Stevan Geoffrey Severtson et al.   DRUG AND ALCOHOL DEPENDENCE

Abuse and Diversion of Gabapentin Among Nonmedical Prescription Opioid Users in Appalachian Kentucky

(2015) Rachel V. Smith et al.   AMERICAN JOURNAL OF PSYCHIATRY

Trends in Opioid Analgesic Abuse and Mortality in the United States

(2015) Richard C. Dart et al.   NEW ENGLAND JOURNAL OF MEDICINE

Potentiation of the Effect of Buprenorphine/Naloxone With Gabapentin or Quetiapine

(2014) Roy R. Reeves et al.   AMERICAN JOURNAL OF PSYCHIATRY

Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?

(2014) Fabrizio Schifano   CNS DRUGS

Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers

(2013) Colin R.W. Baird et al.   EUROPEAN ADDICTION RESEARCH

A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

(2010) Howard N. Bockbrader et al.   CLINICAL PHARMACOKINETICS

Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients

(2008) Magdi Hanna et al.   EUROPEAN JOURNAL OF PAIN